Published by:
Harvard Business Publishing
Length: 4 pages
Share a link:
https://casecent.re/p/42653
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
When Biogen received approval for a breakthrough drug for treating multiple sclerosis, it had to quickly get the product to market. So it circumvented the traditional supply chain and joined with partners to become a virtual manufacturer.
About
Abstract
When Biogen received approval for a breakthrough drug for treating multiple sclerosis, it had to quickly get the product to market. So it circumvented the traditional supply chain and joined with partners to become a virtual manufacturer.